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ABSTRACT
Motivation: Array-based comparative genomic hybridization
(arrayCGH) has recently become a popular tool to identify
DNA copy number variations along the genome. These profiles
are starting to be used as markers to improve prognosis or
diagnosis of cancer, which implies that methods for automated
supervised classification of arrayCGH data are needed. Like
gene expression profiles, arrayCGH profiles are characterized
by a large number of variables usually measured on a limited
number of samples. However, arrayCGH profiles have a
particular structure of correlations between variables, due to
the spatial organization of BACs along the genome. This
suggests that classical classification methods, often based on
the selection of a small number of discriminative features, may
not be the most accurate methods and may not produce easily
interpretable prediction rules.
Results:We propose a new method for supervised classification
of arrayCGH data. The method is a variant of support vector
machine (SVM) that incorporates the biological specificities
of DNA copy number variations along the genome as prior
knowledge. The resulting classifier is a sparse linear classifier
based on a limited number of regions automatically selected
on the chromosomes, leading to easy interpretation and
identification of discriminative regions of the genome. We test
this method on three classification problems for bladder and
uveal cancer, involving both diagnosis and prognosis. We
demonstrate that the introduction of the new prior on the
classifier leads not only to more accurate predictions, but also
to the identification of known and new regions of interest in the
genome.
Availability: All data and algorithms are publicly available.
Contact: franck.rapaport@curie.fr
1 INTRODUCTION
Genome integrity is essential to cell life and is ensured in
normal cells by a series of checkpoints, which enable DNA
repair or trigger cell death to avoid abnormal genome cells
to appear. The p53 protein is probably the most prominent
protein known to play this role. When these checkpoints are
bypassed the genome may evolve and undergo alterations to
∗to whom correspondence should be addressed
a point where the cell can become premalignant and further
genome alterations lead to invasive cancers.
This genome instability has been shown to be an enabling
characteristic of cancer (Hanahan and Weinberg, 2000), and
almost all cancers are associated with genome alterations.
These alterations may be single mutations, translocations, or
copy number variations (CNVs). A CNV can be a deletion or
a gain of small or large DNA regions, an amplification, or an
aneuploidy (change in chromosome number).
Many cancers present recurrent CNVs of the genome,
like for example monoploidy of chromosome 3 in uveal
melanoma (Speicher et al., 1994), loss of chromosome 9
and amplification of the region of cyclin D1 (11q13) in
bladder carcinomas (Blaveri et al., 2005), loss of 1p and
gain of 17q in neuroblastoma (Bown et al., 2001; Van Roy
et al., 2002), EGFR amplification and deletion in 1p and
19q in gliomas (Idbaih et al., 2007), or amplifications of 1q,
8q24, 11q13, 17q21-q23, and 20q13 in breast cancer (Yao
et al., 2006). Moreover associations of specific alterations with
clinical outcome have been described in many pathologies (eg.,
Lastowska et al., 1997).
Recently array-based comparative genomic hybridization
(arrayCGH) has been developed as a technique allowing rapid
mapping of CNVs of a tumor sample at a genomic scale
(Pinkel et al., 1998). The technique was first based on arrays
using a few thousands of large insert clones (like BACs, and
with a Mb range resolution) to interrogate the genome, and
then improved with oligonucleotide based arrays consisting of
several hundreds of thousands features, taking the resolution
down to a few kb (Gershon, 2005). Many projects have since
been launched to systematically detect genomic aberrations in
cancer cells (van Beers and Nederlof, 2006; Chin et al., 2006;
Shing et al., 2003).
The etiology of cancer and the advent of arrayCGH make
it natural to envisage building classifiers for prognosis or
diagnosis based on the genomic profiles of tumors. Building
classifiers based on expression profiles is an active field of
research, but little attention has been paid yet to genome-
based classification. Chin et al. (2006) select a small subset of
genes and apply a k-nearest neighbor classifier to discriminate
between estrogen-positive and estrogen-negative patients,
between high-grade patients and low-grade patients and
between bad prognosis and good prognosis for breast cancer.
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Jones et al. (2004) reduce the DNA copy number estimates
to “gains” and “losses” at the chromosomal arm resolution,
before using a nearest centroid method for classifying breast
tumors according to their grade. As underlined in Chin et al.
(2006), the classification accuracy reported in Jones et al.
(2004) is better than the one reported in Chin et al. (2006),
but still remains at a fairly high level with as much as 24%
of misclassified samples in the balanced problem. This may
be related to the higher resolution of the arrays produced by
Jones et al. (2004). Moreover, the approach used by Jones et al.
(2004) produces a classifier difficult to interpret as it is unable
to detect any deletion or amplification that occur at the local
level. O’Hagan et al. (2003) used a support vector machine
(SVM) classifier using as variables all BAC ratios without any
missing values. They were able to identify key CNAs.
The methods developed so far either ignore the particularities
of arrayCGH and the inherent correlation structure of the data
(O’Hagan et al., 2003), or drastically reduce the complexity of
the data at the risk of filtering out useful information (Jones
et al., 2004; Chin et al., 2006). In all cases, a reduction of the
complexity of the data or a control of the complexity of the
predictor estimated is needed to overcome the risk of overfitting
the training data, given that the number of probes that form
the profile is often several orders of magnitude larger than the
number of samples available to train the classifier.
In this paper we propose a new method for supervised
classification, specifically designed for the processing of
arrayCGH profiles. In order not to miss potentially relevant
information that may be lost if the profiles are first processed
and reduced to a small number of homogeneous regions, we
estimate directly a linear classifier at the level of individual
probes. Yet, in order to control the risk of overfitting, we
define a prior on the linear classifier to be estimated. This prior
encodes the hypothesis that (i) many regions of the genome
should not contribute to the classification rule (sparsity of the
classifier), and (ii) probes that contribute to the classifier should
be grouped in regions on the chromosomes, and be given the
same weight within a region. This a priori information helps
reducing the search space and produces a classification rule
that is easier to interpret. This technique can be seen as an
extension of SVM where the complexity of the classifier is
controlled by a penalty function similar to the one used in the
fused lasso method to enforce sparsity and similarity between
successive features (Tibshirani et al., 2005). We therefore call
the method a fused SVM. It produces a linear classifier that is
piecewise constant on the chromosomes, and only involves a
small number of loci without any a priori regularisation of the
data. From a biological point of view, it avoids the prior choice
of recurrent regions of alterations, but produces a posteriori a
selection of discriminant regions which are then amenable to
further investigations.
We test the fused SVM on several public datasets involving
diagnosis and prognosis applications in bladder and uveal
cancer, and compare it with a more classical method
involving feature selection without prior information about the
organization of probes on the genome. In a cross-validation
setting, we show that the classification rules obtained with the
fused SVM are systematically more accurate than the rules
obtained with the classical method, and that they are also more
easily interpretable.
2 METHODS
In this section we present an algorithm for the supervised classification
of arrayCGH data. This algorithm, which we call fused SVM, is
motivated by the linear ordering of the features along the genome
and the high dependancy in behaviour of neighbouring features. The
algorithm itself estimates a linear predictor by borrowing ideas from
recent methods in regression, in particular the fused lasso (Tibshirani
et al., 2005). We start by a rapid description of the arrayCGH
technology and data, before presenting the fused SVM in the context
of regularized linear classification algorithms.
2.1 ArrayCGH data
ArrayCGH is a microarray-based technology that allows the
quantification of the DNA copy number of a sample at many positions
along the genome in a single experiment. The array contains thousands
to millions of spots, each of them consisting of the amplified or
synthesized DNA of a particular region of the genome. The array is
hybridized with the DNA extracted from a sample of interest, and in
most cases with (healthy) reference DNA. Both samples have first been
labelled with two different fluorochromes, and the ratio of fluorescence
of both fluorochromes is expected to reveal the ratio of DNA copy
number at each position of the genome. The log-ratio profiles can then
be used to detect the regions with abnormalities (log-ratio significantly
different of 0), corresponding to gains (if the log-ratio is significantly
superior to 0) or losses (if it is significantly inferior to 0).
The typical density of arrayCGH ranges from 2400 BAC features
in the pioneering efforts, corresponding to one approximately 100
kb probe every Mb (Pinkel et al., 1998), up to millions today,
corresponding to one 25 to 70bp oligonucleotide probe every few kb,
or even tiling arrays (Gershon, 2005).
There are two principal ways to represent arrayCGH data: as a log-
ratio collection, or as a collection of status (lost, normal or gained,
usually represented as -1, 0 and 1 which correspond to the sign of the
log ratio). The status representation has strong advantages over the log-
ratio as it reduces the complexity of the data, provides the scientist with
a direct identification of abormalities and allows the straightforwad
detection of recurrent alterations. However, converting ratios into status
is not always obvious and often implies a loss of information which can
be detrimental to the study: for several reasons such as heterogeneity
of the sample or contamination with healthy tissue (which both result
in cells with different copy numbers in the sample), the status may
be difficult to infer from the data, whereas the use of the ratio values
avoids this problem. Another problem is the low subtelty of statuses. In
particular, if we want to use arrayCGH for discriminating between two
subtypes of tumors or between tumors with different future evolution,
all tumors may share the same important genomic alterations that are
easily captured by the status assignment while differences between
the types of tumors may be characterized by more subtle signals that
would disappear should we transform the log ratio values into statuses.
Therefore, we consider below an arrayCGH profile as a vector of
log-ratios for all probes in the array.
2.2 Classification of arrayCGH data
While much effort has been devoted to the analysis of single arrayCGH
profiles, or populations of arrayCGH profiles in order to detect genomic
alterations shared by the samples in the population, we focus on the
supervised classification of arrayCGH. The typical problem we want
to solve is, given two populations of arrayCGH data corresponding to
two populations of samples, to design a classifier that is able to predict
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which population any new sample belongs to. This paradigm can be
applied for diagnosis or prognosis applications, where the populations
are respectively samples of different tumor types, or with different
evolution. Although we only focus here on binary classification, the
techniques can be easily extended to problems involving more than
two classes using, for example, a series of binary classifiers trained
to discriminate each class against all others.
While accuracy is certainly the first quality we want the classifier to
have in real diagnosis and prognosis application, it is also important
to be able to interpret it and understand what the classification is
based on. Therefore we focus on linear classifiers, which associate
a weight to each probe and produce a rule that is based on a linear
combination of the probe log-ratios. The weight of a probe roughly
corresponds to its contribution in the final classification rule, and
therefore provides evidence about its importance as a marker to
discriminate the populations. It should be pointed out, however, that
when correlated features are present, the weight of a feature is not
directly related to the individual correlation of the feature with the
classification, hence some care should be taken for the interpretation
of linear classifier.
In most applications of arrayCGH classification, it can be expected
that only a limited number of regions on the genome should contribute
to the classification, because most parts of the genome may not differ
between populations. Moreover, the notion of discriminative regions
suggest that a good classifier should detect these regions, and typically
be piecewise constant over them. We show below how to introduce
these prior hypotheses into the linear classification algorithm.
2.3 Linear supervised classification
Let us denote by p the number of probes hybridized on the arrayCGH.
The result of an arrayCGH competitive hybridization is then a vector
of p log-ratios, which we represent by a vector x in the vector space
X = Rp of possible arrayCGH profiles. We assume that the samples
to be hybridized can belong to two classes, which we represent by
the labels −1 and +1. The classes typically correspond to the disease
status or the prognosis of the samples. The aim of binary classification
is to find a decision function that can predict the class y ∈ {−1,+1}
of a data sample x ∈ X . Supervised classification uses a database of
samples x1, ..., xn ∈ X for which the labels y1, ..., yn ∈ {−1,+1}
are known in order to construct the prediction function. We focus on
linear decision functions, which are defined by functions of the form
f(x) = w⊤x where w⊤ is the transpose of a vector w ∈ Rd. The
class prediction for a profile x is then +1 if f(x) ≥ 0, and −1
otherwise. Training a linear classifier amounts to estimating a vector
w ∈ Rd from prior knowledge and the observation of the labeled
training set.
The training set can be used to assess whether a candidate vector
w can correctly predict the labels on the training set; one may expect
such a w to correctly predict the classes of unlabeled samples as
well. This induction principle, sometimes referred to as empirical
risk minimization, is however likely to fail in our situation where the
dimension of the samples (the number of probes) is typically larger
than the number of training points. In such a case, many vectors w can
indeed perfectly explain the labels of the training set, without capturing
any biological information. These vectors are likely to poorly predict
the classes of new samples. A well-known strategy to overcome this
overfitting issue, in particular when the dimension of the data is large
compared to the number of training points available, is to look for
large-margin classifiers constrained by regularization (Vapnik, 1998).
A large-margin classifier is a prediction function f(x) that not only
tends to produce the correct sign (positive for labels +1, negative for
class −1), but also tends to produce large absolute values. This can
be formalized by the notion of margin, defined as yf(x): large-margin
classifiers try to predict the class of a sample with large margin. Note
that the prediction is correct if the margin is positive. The margin can
be thought of as a measure of confidence in the prediction given by the
sign of f , so a large margin is synonymous with a large confidence.
Training a large-margin classifier means estimating a function f that
takes large margin values on the training set. However, just like for
the sign of f , if p > n then it is possible to find vectors w that
lead to arbitrarily large margin on all points of the training set. In
order to control this overfitting, large-margin classifiers try to maximize
the margin of the classifier on the training set under some additional
constraint on the classifier f , typically that w is not too “large”. In
summary, large-margin classifiers find a trade-off between the objective
to ensure large margin values on the training set, on the one hand, and
that of controlling the complexity of the classifier, on the other hand.
The balance in this trade-off is typically controlled by a parameter of
the algorithm.
More formally, large-margin classifiers typically require the
definition of two ingredients:
• A loss function l(t) that is “small” when t ∈ R is “large”.
From the loss function one can deduce the empirical risk of a
candidate vector w, given by the average loss function applied to
the margins of w on the training set:
Remp(w) =
1
n
nX
i=1
l(yiw
⊤
i x) . (1)
The smaller the empirical risk, the better w fits the training set
in the sense of having a large margin. Typical loss functions are
the hinge loss l(t) = max(0, 1 − t) and the logit loss l(t) =
log
`
1 + e−t
´
.
• A penalty function Ω(w) that measures how “large” or how
“complex” w is. Typical penalty functions are the L1 and L2
norms of w, defined respectively by ||w||1 =
Pp
i=1 |wi| and
||w||2 =
`Pp
i=1 w
2
i
´ 1
2 .
Given a loss function l and a penalty function Ω, large-margin
classifiers can then be trained on a given training set by solving the
following constrained optimization problem:
min
w∈Rp
Remp(w) subject to Ω(w) ≤ µ , (2)
where µ is a parameter that controls the trade-off between fitting
the data, i.e., minimizing Remp(f), and monitoring the regularity
of the classifier, i.e., monitoring Ω(w). Examples of large-margin
classifiers include the support vector machine (SVM) and kernel
logistic regression (KLR) obtained by combining respectively the hinge
and logit losses with the L2 norm penalization function (Cortes and
Vapnik, 1995; Boser et al., 1992; Vapnik, 1998), or the 1-norm SVM
when the hinge loss is combined with the L1 loss .
The final classifier depends on both the loss function and the penalty
function. In particular, the penalty function is useful to include prior
knowledge or intuition about the classifier one expects. For example,
the L1 penalty function is widely used because it tends to produce
sparse vectors w, therefore performing an automatic selection of
features. This property has been successfully used in the context of
regression (Tibshirani, 1996), signal representation (Chen et al., 1998),
survival analysis (Tibshirani, 1997), logistic regression (Genkin et al.,
2007; Krishnapuram et al., 2004), or multinomial logistic regression
(Krishnapuram et al., 2005), where one expects to estimate a sparse
vector.
2.4 Fused lasso
Some authors have proposed to design specific penalty functions as a
means to encode specific prior informations about the expected form
of the final classifier. In the context of regression applied to signal
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processing, when the data is a time series, Land and Friedman (1996)
propose to encode the expected positive correlation between successive
variables by choosing a regularisation term that forces successive
variables of the classifier to have similar weights. More precisely,
assuming that the variables w1, w2, . . . , wp are sorted in a natural
order where many pairs of successive values are expected to have the
same weight, they propose the variable fusion penalty function:
Ωfusion(w) =
n−1X
i=1
|wi − wi+1| . (3)
Plugging this penalty function in the general algorithm (2) enforces
a solution w with many successive values equal to each others, that
is, tends to produce a piecewise constant weight vector. In order to
combine this interesting property with a requirement of sparseness of
the solution, Tibshirani et al. (2005) proposed to combine the lasso
penalty and the variable fusion penalty into a single optimization
problem with two constraints, namely:
min
w∈Rn
Remp(w)
under the constraints
n−1X
i=1
|wi − wi+1| ≤ µ
‖w‖1 ≤ λ ,
(4)
where λ and µ are two parameters that control the relative trade-offs
between fitting the training data (small Remp), enforcing sparsity
of the solution (small λ) and enforcing the solution to be piecewise
constant (small µ). When the empirical loss is the mean square error in
regression, the resulting algorithm is called fused lasso. This method
was illustrated in Tibshirani et al. (2005) with examples taken from
gene expression datasets and mass spectrometry. Later, Tibshirani and
Wang (2007) proposed a tweak of the fused lasso for the purpose of
signal smoothing, and illustrated it for the problem of discretising noisy
CGH profiles.
2.5 Fused SVM
Remembering from Section 2.2 that for arrayCGH data classification
one typically expects the “true” classifier to be sparse and piecewise
constant along the genome, we propose to extend the fused lasso to
the context of classification and adapt it to the chromosome structure
for arrayCGH data classification. The extension of fused lasso from
regression to large-margin classification is obtained simply by plugging
the fused lasso penaly constraints into a large-margin empirical risk
in (4). In what follows we focus on the empirical risk (1) obtained
from the hinge loss, which leads to a simple implementation as a
linear program (see Section 2.6 below). The extension to other convex
loss functions, in particular the logit loss function, results in convex
optimization problems with linear constraints that can be solved with
general convex optimization solvers (Boyd and Vandenberghe, 2004).
In the case of arrayCGH data, a minor modification to the variable
fusion penalty (3) is necessary to take into account the structure of the
genome in chromosomes. Indeed, two successive spots on the same
chromosome are prone to be subject to the same amplification and
are therefore likely to have similar weights on the classifier; however,
this positive correlation is not expected across different chromosomes.
Therefore we restrict the pairs of successive features appearing in
the function constraint (3) to be consecutive probes on the same
chromosome.
We call the resulting algorithm a fused SVM, which can be formally
written as the solution of the following problem:
min
w∈Rp
nX
i=1
max(0, 1− yiw
⊤xi)
under the constraints
X
i∼j
|wi − wj | ≤ µ
X
i=1
|wi| ≤ λ ,
(5)
where i ∼ j if i and j are the indices of succesive spots of the
same chromosome. As with fused lasso, this optimisation problem
tends to produce classifiers w with similar weights for consecutive
features, while maintaining its sparseness. This algorithm depends on
two paramters, λ and µ, which are typically chosen via cross-validation
on the training set. Decreasing λ tends to increase the sparsity of w,
while decreasing µ tends to enforce successive spots to have the same
weight.
This classification algorithm can be applied to CGH profiles, taking
the ratios as features. Due to the effect of both regularisation terms, we
obtain a sparse classification function that attributes similar weights to
successive spots.
2.6 Implementation of the fused SVM
Introducing slack variables, the problem described in (5) is equivalent
to the following linear program :
min
w,α,β,γ
nX
i=1
αi under the following constraints :
∀i = 1, ..., n αi ≥ 0
∀i = 1, ..., n αi ≥ 1− w
⊤xiyi
nX
i=1
βi ≤ λ
∀i = 1, ..., p βi ≥ wi
∀i = 1, ..., p βi ≥ −wi
qX
k=1
γk ≤ µ
∀i, j such that i ∼ j γk ≥ wi − wj
∀i, j such that i ∼ j γk ≥ wj − wi
(6)
In our experiments, we implemented and solved this problem using
Matlab and the SeDuMi 1.1R3 optimisation toolbox (Sturm, 1999).
3 DATA
We consider two publicly available arrayCGH datasets for
cancer research, from which we deduce three problems of
diagnosis and prognosis to test our method.
The first dataset contains arrayCGH profiles of 57 bladder
tumor samples (Stransky et al., 2006). Each profile gives the
relative quantity of DNA for 2215 spots. We removed the
probes corresponding to sexual chromosomes, because the sex
mismatch between some patients and the reference used makes
the computation of copy number less reliable, giving us a
final list of 2143 spots. We considered two types of tumor
classification: either by grade, with 12 tumors of grade 1 and
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45 tumors of higher grades (2 or 3) or by stage, with 16
tumors of stage Ta and 32 tumors of stage T2+. In the case of
stage classification, 9 tumors with intermediary stage T1 were
excluded from the classification.
The second dataset contains arrayCGH profiles for 78
melanoma tumors that have been arrayed on 3750 spots (Trolet
et al., 2008). As for the bladder cancer dataset, we excluded the
sexual chromosomes from the analysis, resulting in a total of
3649 spots. 35 of these tumors lead to the development of liver
metastases within 24 months, while 43 did not. We therefore
consider the problem of predicting, from an arrayCGH profile,
whether or not the tumor will metastasize within 24 months.
In both datasets, we replaced the missing spots log-ratios
by 0. In order to assess the performance of a classification
method, we performed a cross-validation for each of the three
classification problems, following a leave-one-out procedure
for the bladder dataset and a 10-fold procedure for the
melanoma dataset. We measure the number of misclassified
samples for different values of parameters λ and µ.
4 RESULTS
In this section, we present the results obtained with the fused
SVM on the datasets described in the previous section. As
a baseline method, we consider a L1-SVM which minimizes
the mean empirical hinge loss suject to a constraint on the L1
norm of the classifier in (2). The L1-SVM performs automatic
feature selection, and a regularization parameter λ controls the
amount of regularization. It has been shown to be a competitive
classification method for high-dimensional data, such as gene
expression data (Zhu et al., 2004). In fact the L1-SVM is a
particular case of our fused SVM, when the µ parameter is
chosen large enough to relax the variable fusion constraint (3),
typically by taking µ > 2λ. Hence by varying µ from a large
value to 0, we can see the effect of the variable fusion penalty
on the classical L1-SVM.
4.1 Bladder tumors
The upper plot of Figure 1 show the estimated accuracy (by
Leave One Out (LOO)) of the fused SVM as a function of
the regularization parameters λ and µ, for the classification
by grade of the bladder tumors. The middle plot of Figure
1 represents the best linear classifier found by the L1-SVM
(corresponding to λ = 256), while the lower plot shows the
linear classifier estimated from all samples by the fused SVM
when λ and µ are set to values that minimise the LOO error,
namely λ = 32 and µ = 1. Similarly, Figure 2 shows the same
results (LOO accuracy, L1-SVM and fused SVM classifiers)
for the classification of bladder tumors according to their stage.
In both cases, when µ is large enough to make the
variable fusion inactive in (5), then the classifier only finds a
compromise between the empirical risk and the L1 norm of
the classifier. In other words, we recover the classical L1 SVM
with parameter λ. Graphically, the performance of theL1 SVM
for varying λ can be seen on the upper side of each plot of the
LOO accuracy in Figures 1 and 2. Interestingly, in both cases
we observe that the best performance obtained when both λ and
µ can be adjusted is much better than the best performance of
the L1 SVM, when only λ can be adjusted. In the case of grade
classification, the number of misclassified samples drops from
12 (21%) to 7 (12%), while in the case of stage classification
it drops from 13 (28%) to 7 (15%). This suggests that the
additional constraint that translates our prior knowlege about
the structure of the spot positions on the genome is beneficial
in terms of classifier accuracy.
As expected, there are also important differences in the
visual aspects of the classifiers estimated by the L1-SVM and
the fused SVM. The fused SVM produces sparse and piecewise
constant classifiers, amenable to further investigations, while
it is more difficult to isolate from the L1-SVM profiles the
key features used in the classification, apart from a few strong
peaks.
As we can see by looking at the shape of the fused SVM
classifier in Figure 1, the grade classification function is
characterised by non-null constant values over a few small
chromosomal regions and numerous larger regions. Of these
regions, a few are already known as being altered in bladder
tumors, such as the gain on region 1q (Corson et al., 2005).
Moreover some of them have already been shown to be
correlated with grade, such as chromosome 7 (Waldman et al.,
1991).
On the contrary, the stage classifier is characterised by only
a few regions with most of them involving large portions of
chromosomes. They concern mainly chromosome 4, 7, 8q,
11p, 14, 15, 17, 20, 21 and 22, with in particular a strong
contribution from chromosomes 4, 7 and 20. These results
on chromosomes 7, 8q, 11p and 20 are in good agreement
with Blaveri et al. (2005) who identified the most common
alterations according to tumor stage on a set of 98 bladder
tumors.
4.2 Melanoma tumors
Similarly to Figures 1 and 2, the three plots in Figure 3
show respectively the accuracy, estimated by 10-fold cross-
validation, of the fused SVM as a function of the regularisation
parameters λ and µ, the linear classifier estimated by the L1-
SVM when λ is set to the value that minimizes the estimated
error (λ = 4), and the linear classifier estimated by a fused
SVM on all samples when λ and µ are set to values that
minimise the 10-fold error, namely λ = 64 and µ = 0.5.
Similarly to the bladder study, the performance of the
L1-SVM without the fusion constraint can be retrieved by
looking at the upper part of the plot of Figure 3. The fused
classifier offers a slightly improved performance compared
to the standard L1-SVM (17 errors (22%) versus 19 errors
(24%)), even though the amelioration seems more marginal
compared to the improvement made with bladder tumors and
the misclassification rate remains fairly high.
As for the bladder datasets, the L1-SVM and fused SVM
classifiers are markedly different. The L1-SVM classifier is
based only on a few BAC concentrated on chromosome 8,
with positive weights on the 8p arm and negative weights
on the 8q arm. These features are biologically relevant, and
correspond to a known genomic alterations (loss of 8p and gain
of 8q in metastatic tumors). The presence of a strong signal
concentrated on chromosome 8 for the prediction of metastasis
5
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Fig. 1. The figure on the upper side represents the number of
misclassified samples in a leave-one-out error loop on the bladder
cancer dataset with the grade labelling, with its color scale for different
values of the parameters λ and µ which vary logarithmically along the
axes. The weights of the best classifier, for classical L1-SVM (middle)
and for fused SVM (lower part) are ordered and represented in a blue
line, annotated with the chromosome separation (red line).
0.5
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λ
Fig. 2. The figure on the upper side represents the number of
misclassified samples in a leave-one-out error loop on the bladder
cancer dataset with the stage labelling, with its color scale, for different
values of the parameters λ and µ which vary logarithmically along the
axes. The weights of the best classifier, for classical L1-SVM (middle)
and for fused-SVM (lower part) are ordered and represented in a blue
line, annotated with the chromosome separation (red line).
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Fig. 3. The figure on the upper part represents the number of
misclassified samples in a ten-fold error loop on the melanoma dataset.
The weights of the best classifier, for classical L1-SVM (middle) and
for fused SVM (lower part) are ordered and represented in a blue line,
annotated with the chromosome separation (red line).
is in this case correctly captured by the sparse L1-SVM, which
explains its relatively good performance.
To the contrary, the fused SVM classifier is characterised
by many CNAs, most of them involving large regions of
chromosomes. Interestingly, we retrieve the regions whose
alteration was already reported as recurrent events of uveal
melanoma: chromosomes 3, 1p, 6q, 8p, 8q, 16q. As expected
the contributions of 8p and 8q are of opposite sign, in
agreement with the common alterations of these regions: loss
of 8p and gain of 8q in etastatic tumors. Interestingly the
contribution of chromosome 3 is limited to a small region
of 3p, and does not involve the whole chromosome as the
frequency of chromosome 3 monosomy would have suggested.
Note that this is consistent with works by Parrella et al. (2003)
and Tschentscher et al. (2001) who delimited small 3p regions
from partial chromosome 3 deletion patients. On the other hand
we also observe that large portions of other chromosomes have
been assigned significant positive or negative weights, such as
chromosomes 1p, 2p, 4, 5, 9q, 11p, 12q, 13, 14, 20, 21. To our
knowledge, they do not correspond to previous observations,
and may therefore provide interesting starting points for further
investigations.
5 DISCUSSION
We have proposed a new method for the supervised
classification of arrayCGH data. Thanks to the use of
a particular regularization term that translates our prior
assumptions into constraints on the classifier, we estimate
a linear classifier that is based on a restricted number of
spots, and gives as much as possible equal weights to
spots located near each other on a chromosome. Results on
real data sets show that this classification method is able
to discriminate between the different classes with a better
performance than classical techniques that do not take into
account the specificities of arrayCGH data. Moreover, the
learned classifier is piecewise constant and therefore lends
itself particularly well to further interpretation, highlighting
in particular selected chromosomal regions with particularly
highly positive or negative weights.
From the methodological point of view, the use of
regularized large-scale classifiers is nowadays widely spread,
especially in the SVM form. Regularization is particularly
important for “small n large p” problems, i.e., when the number
of samples is small compared to the number of dimensions.
An alternative interpretation of such classifiers is that they
correspond to maximum a posteriori classifiers in a Bayesian
framework, where the prior over classifier is encoded in our
penalty function. It is not surprising, then, that encoding prior
knowledge in the penalty function is a mathematically sound
strategy that can be strongly beneficial in terms of classifier
accuracy, in particular when few training samples are available.
The accuracy improvements we observe on all classification
datasets confirm this intuition. Besides the particular penalty
function investigated in this paper, we believe our results
support the general idea that engineering relevant priors for a
particular problem can have important effects on the quality of
the function estimated and paves the way for further research
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on the engineering of such priors in combination with large-
margin classifiers. As for the implementation, we solved a
linear program for each value couple of the regularization
parameters λ and µ, but it would be interesting to generalize
the recent works on path following algorithms to be able to
follow the solution of the optimization problem when λ and µ
vary (Efron et al., 2004).
Another interesting direction of future research concerns the
combination of heterogeneous data, in particular of arrayCGH
and gene expression data. Gene expression variations contain
indeed information complementary to CNV for the genetic
aberrations of the dysfunctioning cell (Stransky et al., 2006),
and their combination is therefore likely to both improve the
accuracy of the classification methods and shed new light on
biological phenomena that are characteristic of each class. A
possible strategy to combine such datasets would be to train a
large-margin classifier with a particular regularization term that
should be adequately designed.
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